Sign in

CIK 0001796280 · Non-accelerated filer

Oric Pharmaceuticals, Inc.

Sign in to watch
Ticker
ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471787157
Phone
(650) 388-5600
Business address
240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Regulation FD disclosure
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 144 Insider Sale of Securities
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 144 Insider Sale of Securities
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13D/A Stake Beneficial Ownership Report
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations · Exit or restructuring costs
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 424B3 Offering Prospectus

Page 4 of 22 · 423 filings